Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Bosko Andjelic"'
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(11)
Over the years, a rising incidence of liver cirrhosis and lymphoma has been observed. Therefore, the risk of having cirrhosis as a comorbidity increases, thus challenging treatment approaches as data on the management of these patients is lacking. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e41a40dad03af7295d78d3c937ac01
https://pubmed.ncbi.nlm.nih.gov/35948478
https://pubmed.ncbi.nlm.nih.gov/35948478
Autor:
Henrik Frederiksen, Milos Maksimovic, Thomas Stauffer Larsen, Jelena Jelicic, Bosko Andjelic, Zoran Bukumiric
Publikováno v:
Jelicic, J, Larsen, T S, Frederiksen, H, Andjelic, B, Maksimovic, M & Bukumiric, Z 2020, ' Statistical challenges in development of prognostic models in diffuse large B-cell lymphoma : Comparison between existing models – A systematic review ', Clinical Epidemiology, vol. 12, pp. 537-555 . https://doi.org/10.2147/CLEP.S244294
Clinical Epidemiology
Jelicic, J, Larsen, T S, Frederiksen, H, Andjelic, B, Maksimovic, M & Bukumiric, Z 2020, ' Statistical challenges in development of prognostic models in diffuse large b-cell lymphoma : Comparison between existing models – A systematic review ', Clinical Epidemiology, vol. 12, pp. 537-555 . https://doi.org/10.2147/CLEP.S244294
Clinical Epidemiology
Jelicic, J, Larsen, T S, Frederiksen, H, Andjelic, B, Maksimovic, M & Bukumiric, Z 2020, ' Statistical challenges in development of prognostic models in diffuse large b-cell lymphoma : Comparison between existing models – A systematic review ', Clinical Epidemiology, vol. 12, pp. 537-555 . https://doi.org/10.2147/CLEP.S244294
Background and Aim: Based on advances in the diagnosis, classification, and management of diffuse large B-cell lymphoma (DLBCL), a number of new prognostic models have been proposed. The aim of this study was to review and compare different prognosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29328a8076d3fadb1bb2b83110f0507c
https://vbn.aau.dk/ws/files/344113962/Jelicic_et_al_2020_Statistical_challenges_in_development_of_prognostic_models_in_diffuse_large_B_cell_lymphoma.pdf
https://vbn.aau.dk/ws/files/344113962/Jelicic_et_al_2020_Statistical_challenges_in_development_of_prognostic_models_in_diffuse_large_B_cell_lymphoma.pdf
Publikováno v:
Jelicic, J, Stauffer Larsen, T, Bukumiric, Z & Andjelic, B 2021, ' The clinical applicability of current prognostic models in follicular lymphoma : A systematic review ', Critical Reviews in Oncology/Hematology, vol. 164, 103418 . https://doi.org/10.1016/j.critrevonc.2021.103418
The Follicular Lymphoma International Prognostic Index (FLIPI) is widely used for risk stratification of patients with follicular lymphoma (FL). Motivated by evolvement in treatment modalities, several prognostic models for FL have been proposed rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083a0005370b938366bdf6e2c12d607e
https://doi.org/10.1016/j.critrevonc.2021.103418
https://doi.org/10.1016/j.critrevonc.2021.103418
Autor:
Vesna Nikolic, Mihailo Smiljanic, Ivan Petković, Bosko Andjelic, Biljana Mihaljevic, Darko Antic, Goran Trajkovic, Aleksandra Sretenovic, Jelena Bila, Vladislava Djurasinovic, Vojin Vukovic, Jelena Jelicic, Milena Todorovic Balint, Olivera Markovic
Publikováno v:
Annals of Hematology. 97:267-276
The prognostic value of the International Prognostic Index (IPI) has been re-evaluated in the rituximab-treated diffuse large B cell lymphoma (DLBCL) patients. Accordingly, National Comprehensive Cancer Network-IPI (NCCN-IPI) has been introduced to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb60aaacbc49bb2ac4ec5f08b6e7744c
https://doi.org/10.1007/s00277-017-3170-z
https://doi.org/10.1007/s00277-017-3170-z
Autor:
Milena Todorovic-Balint, Bela Balint, Biljana Mihaljevic, Jelena Bila, Bosko Andjelic, Dragana Vujic
Publikováno v:
Medical review. 70:47-50
Autologous stem cell transplant with high-dose chemotherapy is considered to be an effective treatment strategy for outcome improvement in lymphoma patients, especially those with refractory and relapsed disease. Despite the feasibility and efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2f69a35818c022c0dd96ce8a5200e60
https://doi.org/10.2298/mpns17s1047t
https://doi.org/10.2298/mpns17s1047t
Publikováno v:
Jelicic, J, Stauffer Larsen, T, Bukumiric, Z, Juul-Jensen, K & Andjelic, B 2021, ' Prognostic models in primary central nervous system lymphoma patients : A systematic review ', Critical Reviews in Oncology/Hematology, vol. 161, 103341 . https://doi.org/10.1016/j.critrevonc.2021.103341
Over the last decade, several prognostic models have been proposed for primary central nervous system lymphoma (PCNSL), but consensus on the optimal model for these patients is absent or lacking. This study aims to review available prognostic models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef054a7a372227a5da50d3c13c442d2
https://doi.org/10.1016/j.critrevonc.2021.103341
https://doi.org/10.1016/j.critrevonc.2021.103341
Autor:
Maja Perunicic Jovanovic, Marjan Micev, Jelena Bila, Milena Todorovic Balint, Biljana Mihaljevic, Jelena Jelicic, Bosko Andjelic, Darko Antic, Jelena Stojsic, Bela Balint, Sonja Pavlovic, Novica Boricic
Publikováno v:
Pathology & Oncology Research. 22:567-577
Prognostic significance of immune microenvironment has been emphasized using the most advanced analysis, with consecutive attempts to reveal prognostic impact of this findings. The aim of this study was to compare and define prognostic significance o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c42ae454dc7a1a5528a9400c84f6d4f
https://doi.org/10.1007/s12253-015-0032-7
https://doi.org/10.1007/s12253-015-0032-7
Autor:
Aleksandra Sretenovic, Biljana Mihaljevic, Jelena Bila, Vladislava Djurasinovic, Milena Todorovic, Vojin Vukovic, Bosko Andjelic, Darko Antic, Jelena Jelicic
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:416-419
Consideration of comorbidity, disability, and frailty represents a significant part of the treatment of elderly multiple myeloma (MM) patients. The aim of study was to analyze the effect of the Charlson Comorbidity Index (CCI) and scale of Instrument
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294b063878831d475d75f61ae2ed7865
https://doi.org/10.1016/j.clml.2015.03.004
https://doi.org/10.1016/j.clml.2015.03.004
Autor:
Bosko Andjelic, Biljana Mihaljevic, Darko Antic, Olivera Simonovic, Lana Macukanovic-Golubovic
Publikováno v:
Vojnosanitetski Pregled, Vol 72, Iss 6, Pp 483-488 (2015)
Background/Aim. Follicular lymphoma (FL) is a B-cell tumor usually with indolent clinical course, yet in some cases the course of the disease can be very aggressive. The aim of the re-search was to determine distribution of patients into prognostic g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd73dba033904546555638439a79fda
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501500014S.pdf
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501500014S.pdf
Autor:
Milena Todorovic-Balint, Jelena Bila, Bosko Andjelic, Darko Antic, Biljana Mihaljevic, Vladislava Djurasinovic
Publikováno v:
Vojnosanitetski Pregled, Vol 72, Iss 1, Pp 26-32 (2015)
Background/Aim. The widely accepted Follicular Lymphoma International Prognostic Index (FLIPI) divides patients into three risk groups based on the score of adverse prognostic factors. The estimated 5-year survival in patients with a high FLIPI score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c455f1862f88a557f04fe05b543c868
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501501026A.pdf
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501501026A.pdf